JCVI backs HPV jab for boys
admin 24th July 2018 Uncategorised 0The Lancet has published full results of a Phase II trial showing the benefit of Lilly’s JAK inhibitor Olumiant in the treatment of global systemic lupus erythematosus (SLE).
More: JCVI backs HPV jab for boys
Source: News